Zied FERJAOUI, who earned a PhD in Materials Science from the University of Lorraine, France, in 2020, is a multidisciplinary researcher whose work integrates biomaterials, nanotechnology, and health sciences. His research focuses on several innovative and complementary areas.
Firstly, he has worked on the design, characterization, and evaluation of advanced pharmaceutical formulations aimed at improving drug efficacy while minimizing undesirable side effects. His work includes the development of functionalized nanoparticles for precise tissue targeting, paving the way for breakthroughs in controlled drug delivery systems.
Secondly, he has been involved in the development of in vitro biodetection assays based on persistent luminescence. This cutting-edge technology significantly enhances the sensitivity of biomarker detection, making it particularly promising for early, non-invasive diagnostic applications.
Additionally, Zied FERJAOUI is developing three-dimensional biomimetic structures that replicate the complexity of bone physiology. These structures, created using porous hydrogels and innovative biofabrication techniques, are designed for regenerative medicine applications, including the repair of damaged bone tissue and the modeling of pathological conditions.
Finally, his scientific approach emphasizes interdisciplinary integration, drawing on concepts from chemistry, physics, and biology to tackle complex challenges.
Zied FERJAOUI, who earned a PhD in Materials Science from the University of Lorraine, France, in 2020, is a multidisciplinary researcher whose work integrates biomaterials, nanotechnology, and health sciences. His research focuses on several innovative and complementary areas.
Firstly, he has worked on the design, characterization, and evaluation of advanced pharmaceutical formulations aimed at improving drug efficacy while minimizing undesirable side effects. His work includes the development of functionalized nanoparticles for precise tissue targeting, paving the way for breakthroughs in controlled drug delivery systems.
Secondly, he has been involved in the development of in vitro biodetection assays based on persistent luminescence. This cutting-edge technology significantly enhances the sensitivity of biomarker detection, making it particularly promising for early, non-invasive diagnostic applications.
Additionally, Zied FERJAOUI is developing three-dimensional biomimetic structures that replicate the complexity of bone physiology. These structures, created using porous hydrogels and innovative biofabrication techniques, are designed for regenerative medicine applications, including the repair of damaged bone tissue and the modeling of pathological conditions.
Finally, his scientific approach emphasizes interdisciplinary integration, drawing on concepts from chemistry, physics, and biology to tackle complex challenges.